HK1163735A1 - Tumor antigen peptide and use thereof - Google Patents

Tumor antigen peptide and use thereof

Info

Publication number
HK1163735A1
HK1163735A1 HK12103966.0A HK12103966A HK1163735A1 HK 1163735 A1 HK1163735 A1 HK 1163735A1 HK 12103966 A HK12103966 A HK 12103966A HK 1163735 A1 HK1163735 A1 HK 1163735A1
Authority
HK
Hong Kong
Prior art keywords
tumor antigen
antigen peptide
peptide
tumor
antigen
Prior art date
Application number
HK12103966.0A
Other languages
English (en)
Inventor
Noriyuki Sato
Tomohide Tsukahara
Satoshi Kawaguchi
Takuro Wada
Original Assignee
Dainippon Sumitomo Pharma Co
Noriyuki Sato
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co, Noriyuki Sato filed Critical Dainippon Sumitomo Pharma Co
Publication of HK1163735A1 publication Critical patent/HK1163735A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70539—MHC-molecules, e.g. HLA-molecules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK12103966.0A 2008-10-20 2012-04-20 Tumor antigen peptide and use thereof HK1163735A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008270078 2008-10-20
PCT/JP2009/068013 WO2010047310A1 (ja) 2008-10-20 2009-10-19 腫瘍抗原ペプチド及びその利用

Publications (1)

Publication Number Publication Date
HK1163735A1 true HK1163735A1 (en) 2012-09-14

Family

ID=42119348

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12103966.0A HK1163735A1 (en) 2008-10-20 2012-04-20 Tumor antigen peptide and use thereof

Country Status (6)

Country Link
US (1) US9260499B2 (xx)
EP (1) EP2363468B1 (xx)
JP (1) JP5606322B2 (xx)
CN (1) CN102257138B (xx)
HK (1) HK1163735A1 (xx)
WO (1) WO2010047310A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017086354A1 (ja) * 2015-11-20 2017-05-26 北海道公立大学法人札幌医科大学 Ｈｌａ－ａ１１拘束性細胞傷害性ｔ細胞エピトープペプチド
JP6857930B2 (ja) * 2018-02-15 2021-04-14 国立大学法人旭川医科大学 がん抗原ペプチド
CN111777678A (zh) * 2019-04-04 2020-10-16 天津亨佳生物科技发展有限公司 一种egfr l858r 新抗原表位肽及其在治疗肿瘤中的应用
CN110790815B (zh) * 2019-11-29 2021-06-25 中国人民解放军陆军军医大学第一附属医院 一种从妇科肿瘤组织中提取天然提呈抗原肽的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083513A (en) * 1993-11-16 2000-07-04 Gerbu Biotechnik Gmbh Method for increasing the yield of antibodies in the techniques of immunology
JP3509199B2 (ja) 1994-06-15 2004-03-22 日本油脂株式会社 乳化剤組成物およびそれを用いた油中水型エマルシヨンの調製方法
JP3752711B2 (ja) 1995-11-02 2006-03-08 日本油脂株式会社 水中油中水型エマルシヨンの調製方法
EP1000084A4 (en) 1997-07-08 2003-03-26 Human Genome Sciences Inc 123 PROTEIN SEPARATED BY HUMAN
JP2002501077A (ja) 1998-01-23 2002-01-15 ベス イスラエル デアコネス メディカル センター Ｍｅｔｈ１およびｍｅｔｈ２のポリヌクレオチドおよびポリペプチド
NZ512052A (en) 1998-12-01 2003-10-31 Sumitomo Pharma Novel tumor antigen protein art-1 and tumor antigen peptide thereof
US6635742B1 (en) 2000-01-25 2003-10-21 Nuvelo, Inc. Antibodies specific for semaphorin-like polypeptides
WO2001094629A2 (en) 2000-06-05 2001-12-13 Avalon Pharmaceuticals Cancer gene determination and therapeutic screening using signature gene sets
AU2002222610A1 (en) 2000-12-13 2002-06-24 Sumitomo Pharmaceuticals Company, Limited Transgenic animal expressing hla-a24 and utilization thereof
AU2001295582A1 (en) 2000-12-20 2002-07-01 GlaxoSmithKline Biologicals (s.a.) Tumour-related antigens
US7171311B2 (en) * 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
JP2005518782A (ja) 2001-09-17 2005-06-30 プロテイン デザイン ラブス， インコーポレイテッド ガンの診断方法、ガンのモジュレータのスクリーニング組成物及び方法
EP1557466B1 (en) * 2002-09-27 2009-09-02 Dainippon Sumitomo Pharma Co., Ltd. Tumor antigen protein and utilization thereof
WO2007119515A1 (ja) * 2006-03-28 2007-10-25 Dainippon Sumitomo Pharma Co., Ltd. 新規腫瘍抗原ペプチド

Also Published As

Publication number Publication date
US20110200629A1 (en) 2011-08-18
US9260499B2 (en) 2016-02-16
CN102257138A (zh) 2011-11-23
JPWO2010047310A1 (ja) 2012-03-22
CN102257138B (zh) 2013-06-19
EP2363468A4 (en) 2012-05-23
JP5606322B2 (ja) 2014-10-15
EP2363468B1 (en) 2014-12-31
WO2010047310A1 (ja) 2010-04-29
EP2363468A1 (en) 2011-09-07

Similar Documents

Publication Publication Date Title
HK1145506A1 (en) Peptides and their use
ZA201104497B (en) Peptide therapeutic conjugates and uses thereof
EP2236514A4 (en) ARTIFICIAL PEPTIDE AND USE THEREOF
EP2006377A4 (en) NEW TUMORANT PEPTIDES
EP2370458A4 (en) PEPTIDES OF NEUREGULIN AND THEIR USE
EP2383283A4 (en) NOGGIN PEPTIDE AND ITS USE
IL232394A0 (en) Peptides and epitopes against p2x7
EP2474555A4 (en) PEPTIDE DERIVED FROM WNT10 AND USE THEREOF
HRP20150195T1 (xx) Antibakterijski peptidi
EP2318429A4 (en) PROMININ-1 PEPTIDE FRAGMENTS AND ITS USE
IL203221A (en) Bioactive peptides and antibodies
EP2346521A4 (en) PEPTIDES AND METHODS OF USE
GB0702022D0 (en) Peptides and their use
EP2388320A4 (en) ANTI-HS6ST2 ANTIBODIES AND USE THEREOF
HK1168622A1 (en) Antigen peptide and use thereof
GB0908868D0 (en) Depsipeptide and their therapeutic use
HK1168363A1 (en) Novel peptide and use thereof
AU2011259204A1 (en) Antigen peptide and use thereof
AU2011259204A8 (en) Antigen peptide and use thereof
ZA201100019B (en) Variant hhip1 protein and methods and uses thereof
EP2285827A4 (en) PEPTIDES AND ITS USE
HK1163735A1 (en) Tumor antigen peptide and use thereof
IL211040A (en) Melanoma antigen peptide and uses
IL213318A0 (en) C1orf59 peptides and vaccines including the same
EP2450374A4 (en) PEPTIDE AND ITS USE

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20231023